The MIDAS Trial is a randomized controlled trial in Manchester, England using Motivational Interventions for Drugs & Alcohol misuse in Schizophrenia. It is led by Professor Christine Barrowclough and operates in both Manchester and London.[1] The trial is, along with the Danish CapOpus trial, among the only trials aimed at this particular group of comorbid substance abusers with schizophrenia.
References
- ^ Berry, Katherine; Allott, Rory; Emsley, Richard; Ennion, Sarah; Barrowclough, Christine (March 2014). “Perceived empowerment in people with a dual diagnosis of schizophrenia spectrum disorder and substance misuse”. Social Psychiatry and Psychiatric Epidemiology. 49 (3): 377–384. doi:10.1007/s00127-013-0776-x. ISSN 1433-9285. PMID 24141697.